Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Arzneimittelforschung ; 54(6): 314-9, 2004.
Article in English | MEDLINE | ID: mdl-15281616

ABSTRACT

An analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection was developed for the determination of pantoprazole (CAS 102625-70-7) in human plasma using lansoprazole (CAS 103577-45-3) as the internal standard. The analyte and internal standard were extracted from the plasma samples by liquid/liquid extraction using diethyl-ether/dichloromethane (70:30; v/v) and chromatographed on a C8 analytical column. The mobile phase consisted of acetonitrile/ water/methanol (57:25:18; v/v/v) + 10 mmol/l acetic acid + 20 mmol/l ammonium acetate. The method has a chromatographic total run time of 4.5 min and was linear within the range 5.0-5,000 ng/ mL. Detection was performed on a triple quadrupole tandem mass spectrometer by Multiple Reaction Monitoring (MRM). The intra- and inter-run precisions calculated from quality control (QC) samples were 4.2 % and 3.2 %, respectively. The accuracies as determined from QC samples were -5.0 % (intra-run) and 2.0 % (inter-run). The method herein described was employed in a bioequivalence study of two tablet formulations of pantoprazole.


Subject(s)
Anti-Ulcer Agents/blood , Benzimidazoles/blood , Omeprazole/analogs & derivatives , Omeprazole/chemistry , Sulfoxides/blood , 2-Pyridinylmethylsulfinylbenzimidazoles , Calibration , Chemistry, Pharmaceutical , Chromatography, Liquid , Humans , Indicators and Reagents , Lansoprazole , Mass Spectrometry , Pantoprazole , Quality Control , Reference Standards , Reproducibility of Results , Therapeutic Equivalency
SELECTION OF CITATIONS
SEARCH DETAIL